Alphabet Inc. - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 117 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alphabet Inc. ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$63,323
+34.5%
14,2620.0%0.00%
+33.3%
Q2 2023$47,065
+15.8%
14,2620.0%0.00%
+50.0%
Q1 2023$40,647
-97.8%
14,262
-94.4%
0.00%
-98.1%
Q4 2022$1,859,690
-10.0%
255,4520.0%0.11%
+2.9%
Q3 2022$2,066,000
+65.0%
255,4520.0%0.10%
+54.4%
Q2 2022$1,252,000
-79.3%
255,4520.0%0.07%
-65.3%
Q1 2022$6,041,000
+33.7%
255,4520.0%0.20%
+79.8%
Q4 2021$4,519,000
-37.3%
255,4520.0%0.11%
-36.3%
Q3 2021$7,206,000
+1.4%
255,452
-62.3%
0.17%
+17.9%
Q2 2021$7,106,000
-11.0%
678,1410.0%0.14%
-55.0%
Q1 2021$7,988,000
+0.6%
678,1410.0%0.32%
-15.5%
Q4 2020$7,941,000
+47.7%
678,1410.0%0.38%
+50.6%
Q3 2020$5,378,000
-56.9%
678,141
-0.6%
0.25%
-56.1%
Q2 2020$12,478,000
+43.9%
682,240
-6.1%
0.58%
+1.2%
Q1 2020$8,670,000
-27.1%
726,189
+1.7%
0.57%
-20.9%
Q4 2019$11,886,000
+150.6%
714,2850.0%0.72%
+406.3%
Q3 2019$4,743,000714,2850.14%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders